These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 10594980)

  • 1. Current studies on the pathogenesis of melioidosis.
    Woods DE; DeShazer D; Moore RA; Brett PJ; Burtnick MN; Reckseidler SL; Senkiw MD
    Microbes Infect; 1999 Feb; 1(2):157-62. PubMed ID: 10594980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of tigecycline in the treatment of acute Burkholderia pseudomallei infection in a murine model.
    Feterl M; Govan B; Engler C; Norton R; Ketheesan N
    Int J Antimicrob Agents; 2006 Nov; 28(5):460-4. PubMed ID: 17046208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The type II O-antigenic polysaccharide moiety of Burkholderia pseudomallei lipopolysaccharide is required for serum resistance and virulence.
    DeShazer D; Brett PJ; Woods DE
    Mol Microbiol; 1998 Dec; 30(5):1081-100. PubMed ID: 9988483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptidyl-Prolyl Isomerase
    Bzdyl NM; Scott NE; Norville IH; Scott AE; Atkins T; Pang S; Sarovich DS; Coombs G; Inglis TJJ; Kahler CM; Sarkar-Tyson M
    Infect Immun; 2019 Oct; 87(10):. PubMed ID: 31331957
    [No Abstract]   [Full Text] [Related]  

  • 5. Burkholderia pseudomallei as an Enteric Pathogen: Identification of Virulence Factors Mediating Gastrointestinal Infection.
    Sanchez-Villamil JI; Tapia D; Borlee GI; Borlee BR; Walker DH; Torres AG
    Infect Immun; 2020 Dec; 89(1):. PubMed ID: 33106293
    [No Abstract]   [Full Text] [Related]  

  • 6. Five-year surveillance for Burkholderia pseudomallei in Thailand from 2000 to 2004: prevalence and antimicrobial susceptibility.
    Paveenkittiporn W; Apisarnthanarak A; Dejsirilert S; Trakulsomboon S; Thongmali O; Sawanpanyalert P; Aswapokee N
    J Med Assoc Thai; 2009 Aug; 92 Suppl 4():S46-52. PubMed ID: 21298845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Characterisation of Burkholderia pseudomallei Lethal Factor 1 (BLF1). A breakthrough against melioidosis].
    Hautbergue G
    Med Sci (Paris); 2012 Mar; 28(3):262-4. PubMed ID: 22480647
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro motility of a population of clinical Burkholderia pseudomallei isolates.
    Boonbumrung K; Wuthiekanun V; Rengpipat S; Day NP; Peacock SJ
    J Med Assoc Thai; 2006 Sep; 89(9):1506-10. PubMed ID: 17100392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An in situ high-throughput screen identifies inhibitors of intracellular
    Bulterys PL; Toesca IJ; Norris MH; Maloy JP; Fitz-Gibbon ST; France B; Toffig B; Morselli M; Somprasong N; Pellegrini M; Schweizer HP; Tuanyok A; Damoiseaux R; French CT; Miller JF
    Proc Natl Acad Sci U S A; 2019 Sep; 116(37):18597-18606. PubMed ID: 31439817
    [No Abstract]   [Full Text] [Related]  

  • 10. Current antimicrobial susceptibility of first-episode melioidosis Burkholderia pseudomallei isolates from the Northern Territory, Australia.
    Crowe A; McMahon N; Currie BJ; Baird RW
    Int J Antimicrob Agents; 2014 Aug; 44(2):160-2. PubMed ID: 24924662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial susceptibility patterns of Burkholderia pseudomallei among melioidosis cases in Kedah, Malaysia.
    Hassan MR; Vijayalakshmi N; Pani SP; Peng NP; Mehenderkar R; Voralu K; Michael E
    Southeast Asian J Trop Med Public Health; 2014 May; 45(3):680-8. PubMed ID: 24974653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efflux-mediated aminoglycoside and macrolide resistance in Burkholderia pseudomallei.
    Moore RA; DeShazer D; Reckseidler S; Weissman A; Woods DE
    Antimicrob Agents Chemother; 1999 Mar; 43(3):465-70. PubMed ID: 10049252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Burkholderia pseudomallei known siderophores and hemin uptake are dispensable for lethal murine melioidosis.
    Kvitko BH; Goodyear A; Propst KL; Dow SW; Schweizer HP
    PLoS Negl Trop Dis; 2012; 6(6):e1715. PubMed ID: 22745846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trimethoprim/sulfamethoxazole resistance in clinical isolates of Burkholderia pseudomallei from Thailand.
    Saiprom N; Amornchai P; Wuthiekanun V; Day NP; Limmathurotsakul D; Peacock SJ; Chantratita N
    Int J Antimicrob Agents; 2015 May; 45(5):557-9. PubMed ID: 25758020
    [No Abstract]   [Full Text] [Related]  

  • 15. Melioidosis: insights into the pathogenicity of Burkholderia pseudomallei.
    Wiersinga WJ; van der Poll T; White NJ; Day NP; Peacock SJ
    Nat Rev Microbiol; 2006 Apr; 4(4):272-82. PubMed ID: 16541135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Farnesol increases the susceptibility of Burkholderia pseudomallei biofilm to antimicrobials used to treat melioidosis.
    Castelo-Branco DS; Riello GB; Vasconcelos DC; Guedes GM; Serpa R; Bandeira TJ; Monteiro AJ; Cordeiro RA; Rocha MF; Sidrim JJ; Brilhante RS
    J Appl Microbiol; 2016 Mar; 120(3):600-6. PubMed ID: 26669506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virulence of the Melioidosis Pathogen Burkholderia pseudomallei Requires the Oxidoreductase Membrane Protein DsbB.
    McMahon RM; Ireland PM; Sarovich DS; Petit G; Jenkins CH; Sarkar-Tyson M; Currie BJ; Martin JL
    Infect Immun; 2018 May; 86(5):. PubMed ID: 29440370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Raising the Stakes: Loss of Efflux Pump Regulation Decreases Meropenem Susceptibility in Burkholderia pseudomallei.
    Sarovich DS; Webb JR; Pitman MC; Viberg LT; Mayo M; Baird RW; Robson JM; Currie BJ; Price EP
    Clin Infect Dis; 2018 Jul; 67(2):243-250. PubMed ID: 29394337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenesis of and immunity to melioidosis.
    Brett PJ; Woods DE
    Acta Trop; 2000 Feb; 74(2-3):201-10. PubMed ID: 10674650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malleilactone Is a Burkholderia pseudomallei Virulence Factor Regulated by Antibiotics and Quorum Sensing.
    Klaus JR; Deay J; Neuenswander B; Hursh W; Gao Z; Bouddhara T; Williams TD; Douglas J; Monize K; Martins P; Majerczyk C; Seyedsayamdost MR; Peterson BR; Rivera M; Chandler JR
    J Bacteriol; 2018 Jul; 200(14):. PubMed ID: 29735757
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.